Scientist, PhD, M.Sc.
Dr. Mark Harrison joined CHÉOS and the University of British Columbia (UBC) Faculty of Pharmaceutical Sciences in August 2014. He also has affiliations with Arthritis Research Canada, St. Paul’s Hospital and the Collaboration for Outcomes Research and Evaluation (CORE) in UBC’s Faculty of Pharmaceutical Sciences, and leads the faculty’s Initiative for Sustainable Health Care.
He has a first-class Honours degree in Business and Management Sciences (University of Bradford, 2000), an M.Sc. (University of Edinburgh, 2002) and PhD (University of Manchester, 2008) in Epidemiology.
Dr. Harrison’s main methodological and research interests lie in the measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions. His research focuses on evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered. Before moving to UBC, Dr. Harrison worked at the University of Manchester (United Kingdom) on a range of projects, including evaluating the impact of incentive schemes to improve the quality of primary care on hospitalizations, patient-reported outcome measures to evaluate surgical outcomes and the communication of risk to patients.